Broadening The Involvement Of Pharmacists In Non-Alcoholic Fatty Liver Disease Management

Abstract

Non-alcoholic fatty liver disease (NAFLD) presents an increasingly urgent global health concern, emphasizing the importance of timely identification for effective treatment and the prevention of chronic liver conditions' progression. Given the anticipated shortage of specialized healthcare professionals, particularly hepatologists and gastroenterologists, the role of pharmacists assumes a crucial position in NAFLD management. This article highlights the potential of pharmacists in community pharmacy settings, not as diagnosticians, but as facilitators in identifying and screening individuals at elevated NAFLD risk using validated non-invasive tools like portable devices and calculators. By prioritizing patient education, referrals, and continuous monitoring, pharmacists can enhance NAFLD management, ultimately improving patient outcomes. Strengthening the impact of pharmacists in early NAFLD detection and management can be achieved through collaborations with healthcare institutions and the integration of patient self-assessment tools. This collaborative approach holds promise for advancing liver health within the community.